Literature DB >> 16284256

Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome.

M C Bonaglia, R Giorda, E Mani, G Aceti, B-M Anderlid, A Baroncini, T Pramparo, O Zuffardi.   

Abstract

INTRODUCTION: The 22q13.3 deletion syndrome (MIM 606232) is characterised by neonatal hypotonia, normal to accelerated growth, absent to severely delayed speech, global developmental delay, and minor dysmorphic facial features. We report the molecular characterisation of the deletion breakpoint in two unrelated chromosome 22q13.3 deletion cases.
METHODS: The deletions were characterised by FISH, checked for other abnormalities by array-CGH, and confirmed by Real-Time PCR, and finally the breakpoints were cloned, sequenced, and compared.
RESULTS: Both cases show the cardinal features of the 22q13.3 deletion syndrome associated with a deletion involving the last 100 kb of chromosome 22q13.3. The cases show a breakpoint within the same 15 bp repeat unit, overlapping the results obtained by Wong and colleagues in 1997 and suggesting that a recurrent deletion breakpoint exists within the SHANK3 gene. The direct repeat involved in these 22q13 deletion cases is presumably able to form slipped (hairpin) structures, but it also has a strong potential for forming tetraplex structures. DISCUSSION: Three cases with a common breakpoint within SHANK3 share a number of common phenotypic features, such as mental retardation and developmental delay with severely delayed or absent expressive speech. The two cases presented here, having a deletion partially overlapping the commercial subtelomeric probe, highlight the difficulties in interpreting FISH results and suggest that many similar cases may be overlooked.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284256      PMCID: PMC2563164          DOI: 10.1136/jmg.2005.038604

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  28 in total

1.  Regulation of dendritic spine morphology and synaptic function by Shank and Homer.

Authors:  C Sala; V Piëch; N R Wilson; M Passafaro; G Liu; M Sheng
Journal:  Neuron       Date:  2001-07-19       Impact factor: 17.173

2.  Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome.

Authors:  Heidi A Heilstedt; Blake C Ballif; Leslie A Howard; Richard A Lewis; Samuel Stal; Catherine D Kashork; Carlos A Bacino; Stuart K Shapira; Lisa G Shaffer
Journal:  Am J Hum Genet       Date:  2003-04-08       Impact factor: 11.025

3.  Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome.

Authors:  M C Bonaglia; R Giorda; R Borgatti; G Felisari; C Gagliardi; A Selicorni; O Zuffardi
Journal:  Am J Hum Genet       Date:  2001-06-18       Impact factor: 11.025

4.  Mfold web server for nucleic acid folding and hybridization prediction.

Authors:  Michael Zuker
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

5.  Unbalanced translocation t(15;22) in "severe" Prader-Willi syndrome.

Authors:  A Smith; A Jauch; L St Heaps; L Robson; B Kearney
Journal:  Ann Genet       Date:  2000 Jul-Dec

6.  22q13 deletion syndrome.

Authors:  M C Phelan; R C Rogers; R A Saul; G A Stapleton; K Sweet; H McDermid; S R Shaw; J Claytor; J Willis; D P Kelly
Journal:  Am J Med Genet       Date:  2001-06-15

7.  Characterization of terminal deletions at 7q32 and 22q13.3 healed by De novo telomere addition.

Authors:  H Varley; S Di; S W Scherer; N J Royle
Journal:  Am J Hum Genet       Date:  2000-08-01       Impact factor: 11.025

8.  3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome.

Authors:  Lionel Willatt; James Cox; John Barber; Elisabet Dachs Cabanas; Amanda Collins; Dian Donnai; David R FitzPatrick; Eddy Maher; Howard Martin; Josep Parnau; Lesley Pindar; Jacqueline Ramsay; Charles Shaw-Smith; Erik A Sistermans; Michael Tettenborn; Dorothy Trump; Bert B A de Vries; Kate Walker; F Lucy Raymond
Journal:  Am J Hum Genet       Date:  2005-05-25       Impact factor: 11.025

9.  FISH-mapping of a 100-kb terminal 22q13 deletion.

Authors:  Britt-Marie Anderlid; Jacqueline Schoumans; Göran Annerén; Isabel Tapia-Paez; Jan Dumanski; Elisabeth Blennow; Magnus Nordenskjöld
Journal:  Hum Genet       Date:  2002-04-04       Impact factor: 4.132

Review 10.  ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease.

Authors:  Tobias M Boeckers; Jürgen Bockmann; Michael R Kreutz; Eckart D Gundelfinger
Journal:  J Neurochem       Date:  2002-06       Impact factor: 5.372

View more
  80 in total

1.  Clinical utility gene card for: deletion 22q13 syndrome.

Authors:  Katy Phelan; Catalina Betancur
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

2.  Genotype-phenotype relationship in three cases with overlapping 19p13.12 microdeletions.

Authors:  Maria C Bonaglia; Susan Marelli; Francesca Novara; Simona Commodaro; Renato Borgatti; Grazia Minardo; Luigi Memo; Elisabeth Mangold; Silvana Beri; Claudio Zucca; Daniele Brambilla; Massimo Molteni; Roberto Giorda; Ruthild G Weber; Orsetta Zuffardi
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

3.  13q Deletion and central nervous system anomalies: further insights from karyotype-phenotype analyses of 14 patients.

Authors:  Lucia Ballarati; Elena Rossi; Maria Teresa Bonati; Stefania Gimelli; Paola Maraschio; Palma Finelli; Sabrina Giglio; Elisabetta Lapi; Maria Francesca Bedeschi; Silvana Guerneri; Giulia Arrigo; Maria Grazia Patricelli; Teresa Mattina; Oriana Guzzardi; Vanna Pecile; Adalgisa Police; Gioacchino Scarano; Lidia Larizza; Orsetta Zuffardi; Daniela Giardino
Journal:  J Med Genet       Date:  2007-01       Impact factor: 6.318

4.  Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome.

Authors:  Svetlana A Yatsenko; Ellen K Brundage; Erin K Roney; Sau Wai Cheung; A Craig Chinault; James R Lupski
Journal:  Hum Mol Genet       Date:  2009-03-17       Impact factor: 6.150

5.  Shank3-Rich2 interaction regulates AMPA receptor recycling and synaptic long-term potentiation.

Authors:  Fabrice Raynaud; Andrea Janossy; Janine Dahl; Federica Bertaso; Julie Perroy; Annie Varrault; Michel Vidal; Paul F Worley; Tobias M Boeckers; Joël Bockaert; Philippe Marin; Laurent Fagni; Vincent Homburger
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

6.  Loss of predominant Shank3 isoforms results in hippocampus-dependent impairments in behavior and synaptic transmission.

Authors:  Mehreen Kouser; Haley E Speed; Colleen M Dewey; Jeremy M Reimers; Allie J Widman; Natasha Gupta; Shunan Liu; Thomas C Jaramillo; Muhammad Bangash; Bo Xiao; Paul F Worley; Craig M Powell
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

7.  Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.

Authors:  Nadege Bondurand; Florence Dastot-Le Moal; Laure Stanchina; Nathalie Collot; Viviane Baral; Sandrine Marlin; Tania Attie-Bitach; Irina Giurgea; Laurent Skopinski; William Reardon; Annick Toutain; Pierre Sarda; Anis Echaieb; Marilyn Lackmy-Port-Lis; Renaud Touraine; Jeanne Amiel; Michel Goossens; Veronique Pingault
Journal:  Am J Hum Genet       Date:  2007-10-22       Impact factor: 11.025

Review 8.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

Review 9.  Modeling autism by SHANK gene mutations in mice.

Authors:  Yong-Hui Jiang; Michael D Ehlers
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

Review 10.  Therapeutic approaches for shankopathies.

Authors:  Xiaoming Wang; Alexandra L Bey; Leeyup Chung; Andrew D Krystal; Yong-Hui Jiang
Journal:  Dev Neurobiol       Date:  2013-10-11       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.